Brian R Gastman

7PUBLICATIONS
83CO-AUTHORS
Gene and molecular therapyTumour immunologyPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors.

Oliver Bechter, Carmen Loquai, Stephane Champiat

|May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8+ T cell responses.

Hieu Minh Ta, Dia Roy, Keman Zhang

|Nov 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.

Alan Shen, Michelle Arbesman, Roshan Lodha

|Apr 07, 2022
IL-17-induced HIF1α drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion.

Xing Chen, Junjie Zhao, Tomasz Herjan

|Jan 19, 2022
MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.

Dechen Fu, Luke Pfannenstiel, Abeba Demelash

|Nov 22, 2021
A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.

Chuan Li, Yee Peng Phoon, Keaton Karlinsey

Pageof 2

Frequent Collaborators

2 joint publications

Caini Liu

2 joint publications

Xiaoxia Li

2 joint publications

Xing Chen

2 joint publications

Yee Peng Phoon